Cubist Systematic Strategies, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $9,900 - $20,988	-19,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.22 $6,624 - $8,784	7,200 Added 57.14%	19,800 $20,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $8,442 - $19,026	12,600 New	12,600 $16,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $27,900 - $40,920	-37,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $35,712 - $64,728	37,200 New	37,200 $39,000

39M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $774M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.